Scientific and Technological Innovation of SJTU
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
1 Zhirong “Jerry” Zhao
Updated 03/16/2020 ZHIRONG “JERRY” ZHAO Gross Family Professor, Public & Nonprofit Management Hubert H. Humphrey School of Public Affairs, University of Minnesota (UMN) 301 19th Avenue South, Minneapolis, MN 55455 [email protected], 612-625-7318 (phone) BIOGRAPHICAL INFORMATION Education 2005 Ph.D. of Public Administration, University of Georgia (UGA), Athens 1997 Master of Urban Planning, Tongji University, Shanghai, China 1993 Bachelor of Urban Planning, Tongji University, Shanghai, China Academic Positions 2019- pres. Chair Leadership & Management Area, Humphrey School of Public Affairs, UMN 2019–pres. Gross Family Professor, Humphrey School of Public Affairs, UMN 2017- pres. Director, Master of Public Policy Program, Humphrey School of Public Affairs, UMN 2017- pres. Founding Director, Institute for Urban & Regional Infrastructure Finance, UMN 2012–2019 Associate Professor, Humphrey School of Public Affairs, UMN 2007–2011 Assistant Professor, Humphrey School of Public Affairs, UMN 2005–2007 Director, Political Science Internship Program, Eastern Michigan University 2005–2007 Assistant Professor, Department of Political Science, Eastern Michigan University Professional Experience 2002–2005 Education Program Specialist, Carl Vinson Institute of Government, UGA 1993–1998 Assistant Urban Planner, Xiamen Academy of Urban Planning & Design, China Awards and Honors 2020 SCPA Leadership Award, American Society for Public Administration (ASPA) 2018 Outstanding Services Award, Center for Transportation Studies, UMN 2018 Leadership Award, China-America -
Ninghua, ZHONG (钟宁桦)
Ninghua, ZHONG (钟宁桦) Professor, Economics and Finance School of Economics and Management Tongji University, Shanghai [email protected]; [email protected] Academic Background PhD in Finance, Hong Kong University of Science and Technology, January 2013 PhD Committee: Sudipto Dasgupta, Vidan K. Goyal, K. C. John Wei, Albert Park, Zhigang Tao MA in Economics, Peking University, China Center for Economic Research, July 2008 Adviser: Yang Yao BA in Economics with highest distinction, Fudan University, School of Economics, July 2005 GPA: 3.82 out of 4.00 Class rank: 1 out of 109 Current Academic Appointment Professor, School of Economics and Management, Tongji University Promoted to Full Professor in December 2015 due to my exceptional performance Promoted to Associate Professor in June 2013 shortly after joining the university in March 2013 Teaches at one of the premier Executive MBA programs in the world (Tongji University/ENPC), ranked 68th in 2014 by the Financial Times Research interests include (a) applied microeconomics studies in the fields of labor economics, corporate finance, and empirical asset pricing and (b) Chinese economic reform and development Ningua, ZHONG (钟宁桦) 1 Publications and Working Papers—English As of December 2015, Google Scholar calculated 225 citations of my papers: On China’s Labor Market Issues (Papers in this field are developed from my master thesis) “Unions and Workers’ Welfare in Chinese Firms” (with Yang Yao), [download from JSTOR] Journal of Labor Economics 31, no. 3 (2013): 633–67. -
Encephalomyelitis Ameliorates Experimental Autoimmune And
The Journal of Immunology Vibsanin B Preferentially Targets HSP90b, Inhibits Interstitial Leukocyte Migration, and Ameliorates Experimental Autoimmune Encephalomyelitis Bai-Xin Ye,*,1 Xu Deng,†,1 Li-Dong Shao,† Ying Lu,* Run Xiao,* Yi-Jie Liu,* Yi Jin,* Yin-Yin Xie,* Yan Zhao,* Liu-Fei Luo,* Shun Ma,‡ Ming Gao,x Lian-Ru Zhang,‡ Juan He,† Wei-Na Zhang,* Yi Chen,* Cheng-Feng Xia,† Min Deng,{ Ting-Xi Liu,*,{ Qin-Shi Zhao,† Sai-Juan Chen,* and Zhu Chen* Interstitial leukocyte migration plays a critical role in inflammation and offers a therapeutic target for treating inflammation- associated diseases such as multiple sclerosis. Identifying small molecules to inhibit undesired leukocyte migration provides promise for the treatment of these disorders. In this study, we identified vibsanin B, a novel macrocyclic diterpenoid isolated from Viburnum odoratissimum Ker-Gawl, that inhibited zebrafish interstitial leukocyte migration using a transgenic zebrafish line (TG:zlyz– enhanced GFP). We found that vibsanin B preferentially binds to heat shock protein (HSP)90b. At the molecular level, inacti- vation of HSP90 can mimic vibsanin B’s effect of inhibiting interstitial leukocyte migration. Furthermore, we demonstrated that vibsanin B ameliorates experimental autoimmune encephalomyelitis in mice with pathological manifestation of decreased leuko- cyte infiltration into their CNS. In summary, vibsanin B is a novel lead compound that preferentially targets HSP90b and inhibits interstitial leukocyte migration, offering a promising drug lead for treating inflammation-associated diseases. The Journal of Immunology, 2015, 194: 4489–4497. eukocyte trafficking is a multistep process consisting of moattractant signals, plays an important role in immune cell de- transendothelial and interstitial migration of leukocytes, velopment, immunosurveillance, and effector functions. -
Participants: (In Order of the Surname)
Participants 31 Participants: (in order of the surname) Yansong Bai yyyòòòttt: Jilin University, Changchun. E-mail: [email protected] Jianhai Bao ïïï°°°: Central South University, Changsha. E-mail: [email protected] Chuanzhong Chen •••DDD¨¨¨: Hainan Normal University, Haikou. E-mail: [email protected] Dayue Chen •••ŒŒŒ: Peking University, Beijing. E-mail: [email protected] Haotian Chen •••hhhUUU: Jilin University, Changchun. E-mail: [email protected] Longyu Chen •••999ˆˆˆ: Peking University, Beijing. E-mail: [email protected] Man Chen •••ùùù: Capital Normal University, Beijing. E-mail: [email protected] Mu-Fa Chen •••777{{{: Beijing Normal University, Beijing. E-mail: [email protected] Shukai Chen •••ÓÓÓppp: Beijing Normal University, Beijing. E-mail: [email protected] Xia Chen •••ggg: Jilin University, Changchun; University of Tennessee, USA. E-mail: [email protected] Xin Chen •••lll: Shanghai Jiao Tong University, Shanghai. E-mail: [email protected] Xue Chen •••ÆÆÆ: Capital Normal University, Beijing. E-mail: [email protected] Zengjing Chen •••OOO¹¹¹: Shandong University, Jinan. E-mail: [email protected] 32 Participants Huihui Cheng §§§¦¦¦¦¦¦: North China University of Water Resources and Electric Power, Zhengzhou E-mail: [email protected] Lan Cheng §§§===: Central South University, Changsha. E-mail: [email protected] Zhiwen Cheng §§§“““>>>: Beijing Normal University, Beijing. E-mail: [email protected] Michael Choi éééRRRZZZ: The Chinese University of Hong Kong, Shenzhen. E-mail: [email protected] Bowen Deng """ÆÆÆ©©©: Jilin University, Changchun. E-mail: [email protected] Changsong Deng """ttt: Wuhan University, Wuhan. E-mail: [email protected] Xue Ding ¶¶¶ÈÈÈ: Jilin University, Changchun. -
Acupuncture in China
Acupuncture in China A Suggested Curriculum for a 4th-Year Clinical Rotation April 14, 2011 Ben Mervak, Alison Kalinowski, and Malani Gupta Table of Contents A LETTER OF INTRODUCTION ................................................................................................ 2 SUGGESTED LEARNING OBJECTIVES .......................................................................................... 3 INTRODUCTION TO ACUPUNCTURE AND RELATED THERAPIES .......................................................... 4 PATIENT DEMOGRAPHICS ..................................................................................................... 7 SAMPLE AM CLINIC PATIENT LOG ........................................................................................ 8 SAMPLE AM CLINIC PROCEDURE LOG ................................................................................... 9 CASE REPORT .................................................................................................................. 10 1. PLACEMENT OF SCALP NEEDLES ....................................................................................... 11 2. PLACEMENT OF UPPER EXTREMITY NEEDLES ......................................................................... 11 3. PLACEMENT OF ABDOMINAL NEEDLES ................................................................................ 12 4. PLACEMENT OF LOWER EXTREMITY NEEDLES........................................................................ 13 RECOMMENDED REQUIREMENTS FOR FUTURE ROTATORS ............................................................. -
Orthotopic Liver Transplantation for Primary Intrahepatic Adenosquamous Carcinoma Using a Marginal Graft: the First Case Rrport
Orthotopic Liver Transplantation for Primary Intrahepatic Adenosquamous Carcinoma Using A Marginal Graft: the First Case rRport Peng Chen Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital Di Ma Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital Ruokun Li Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital Xiaoqun Yang Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital Hui Tong Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital Debin Qi Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital Tao Li ( [email protected] ) Shanghai Jiao Tong University Medical School Aliated Ruijin Hospital https://orcid.org/0000-0003- 4035-0729 Case report Keywords: case report, cancer/malignancy/neoplasia, primary adenosquamous carcinoma, cholangiocarcinoma, liver transplantation/hepatology Posted Date: December 2nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-117738/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/17 Abstract Background. Primary intrahepatic adenosquamous carcinoma (iASC) is a very rare subtype of cholangiocarcinoma (CCA), with a worse prognosis than adenocarcinoma. Hepatectomy is still the rst choice for iASC, and liver transplantation (LT) for iASC has not been previously reported. Case presentation The young male patient with an unresectable primary iASC underwent a LT using a marginal fatty liver graft. The overall survival of this patient was 16 months, with a recurrence-free survival of 8 months. The patient had a good quality of life with normal liver function until 3 months before death. Conclusions. This is the rst case report of LT as treatment of unresectable iASC using a marginal graft. -
LIU Ming Lecturer Position: Department: Management Science
LIU Ming Lecturer Position: Department: Management Science & Engineering Email: [email protected] Office Phone: 021-65983943 EDUCATION BACKGROUND · 2002-2006: Ph.D, Shanghai University of Finance & Economics · 1995-1998: M.Ec., Shanghai University of Finance & Economics RESEARCH FIELD · Financial Management · Management Accounting · Public Finance TEACHING INTERESTS · Financial Management · Management Accounting WORK EXPERIENCE Teaching Positions · 1993-Now: School of Economics and Management, Tongji University LANGUAGES · Chinese (mother tongue) · English (good) RESEARCH Sponsored Research Projects · Optimization of Financial Management Curriculum System for Undergraduate Based on Professional Category Enrollment Mode, Educational Reform Project,2013, Project Leader · Research on Professional Services Development of Shanghai Hongkou District, Science and Technology Commission of Shanghai Hongkou District, 2010, Project Leader · Controlling Right Transfer and Company Performance, National Social Science Fund of China, 2005. · Study of Performance Evaluation for Public Expenditure, National Natural Science Foundation of China, 2003. Selected Publications Papers · ZHOU Wei, Research on the Construction of Experiment Course of Financial Management for undergraduate, The Proceedings of Educational Research and Educational Reformation, Tongji University Press, 2011(10) · ZHOU Wei, SONG XiaoMan, BAI YunXia, Study on Profit Distribution System of State-owned Enterprise, Finance and Accounting Monthly, 2011(8). In Chinese. · HUANG ZhiZhong, ZHOU Wei, XIE WenLi, Motivation of Strong Stock Holder Underweight: Theories and evidences, Economic Review, 2009 (6). In Chinese. · BAI YunXia, ZHOU Wei, The Impact of the Number of Suppliers on Operating Performance, China Business&Trade, 2009(5). In Chinese. · CONG Shuhai, ZHOU Wei, Performance Evaluation for Chinese Public Expenditure in Education, Finance and Trade Economics, 2007(3). In Chinese. Books · CONG Shuhai, Evaluation of Public Expenditure, Economic Science Publishing House, 2006. -
Leukaemia Section
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Short Communication t(3;11)(q29;p15) Li-Ting Chen, Sai-Juan Chen Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China (L-TC, S-JC) Published in Atlas Database: February 2009 Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t0311q29p15ID1508.html DOI: 10.4267/2042/44667 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2010 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Complex translocation t(3;11)(q29q13;p15)del(3)(q29). A: Red arrow indicates der(3); green arrow indicates der(11). The chromosomes displaying only red color or green color (yellow arrows) are normal chromosomes 11 and 3, respectively. Insert: Representative partial karyotype showing t(3;11). Clinics and pathology Phenotype/cell stem origin Only one case available; BM showed 82.5% blast cells Disease mostly with myeloid features. Immuno-phenotype: Bi-phenotypic acute T-lymphoid/myeloid leukemia CD34+ cells count 35.6%, CD13+ 25.9%, CD33+ 85.4%, MPO+ 20.6% and CD3+ 65.9%, CD7+ 96.5%. Atlas Genet Cytogenet Oncol Haematol. 2010; 14(1) 70 t(3;11)(q29;p15) Chen L-T, Chen S-J Clinics Additional anomalies Only one case available; the patient was a 42-year-old +21 female at diagnosis. After the chemotherapy with vincristine, cytarabine and mitoxantrone, she achieved Genes involved and proteins complete remission (CR), but relapsed after 4 months, and died from intracranial hemorrhage at the 22 nd NUP98 months. -
China Venture Fund
CHINA VENTURE FUND 2018-2019 China Venture Fund Scholars Name Proposal Title Partner Institution(s) Department College North China Plain and Texas High Plains: Collaboration between Geography & the Liberal Arts & Social 1 FeiFei Pan China Agricultural University UNT and China Agricultural Environment Sciences University Collaborative Research Activities Texas Center for Xinghai Conservatory 2 Kris Chesky with the Texas Center for Performing Arts Music Zhaoqing University Performing Arts Health Health Research, Education, and Peking University Recruiting Collaboration with Shanghai Jiao Tong University Biomedical 3 Donghui Zhu Engineering Biomedical Engineering Programs Northwest Institute for Nonferrous Engineering at Top Universities in China Metal Research Housing International Recognized Engineering 4 Cheng Yu Tsinghua University Engineering Researcher on Disaster Mitigation Technology Page 1 of 6 Last Updated: 01/07/2019 CHINA VENTURE FUND 2017-2018 China Venture Fund Scholars Name Proposal Title Partner Institution(s) Department College East China Normal University Enhancing Research & Shanghai University of Sport Kinesiology, Health 1 Tao Zhang Recruitment with Universities in Shanghai University Promotion, & Education China East China Jiaotong University Recreation Beijing Sport University Establishing Education & Engineering 2 Cheng Yu Beijing University of Technology Engineering Research Partnership with BJUT Technology Research and Education Collaboration with School of Computer Science & 3 Yan Huang Computer Science -
Likuo Sung CV July 2020
July 2020 Li-Kuo Sung Curriculum vitae Peking University HSBC Business School Room 651, University Town, Nanshan District, Shenzhen, 518055, China Phone: +86-755-26033627 E-mail: [email protected] ACADEMIC EMPLOYMENT Peking University, Shenzhen, China 2019 - now Assistant Professor, Peking University HSBC Business School Shanghai University of Finance and Economics, Shanghai, China 2016 - 2019 Assistant Professor, College of Business EDUCATION 2015 Ph.D., Owen School of Management, VanDerbilt University, USA 2008 M. A., Human Resources anD InDustrial Relations, Carlson School of Management, University of Minnesota, USA 2005 MBA, National Taiwan University, Taiwan 2001 B.S., Psychology, National Chengchi University, Taiwan B.A., Public Finance, National Chengchi University, Taiwan RESEARCH INTERESTS Pay Dispersion Proactive Behavior Meta-Analysis Job Insecurity WorkPlace Exclusion REFEREED PUBLICATIONS Journal Articles Park, T. Y., Kim, S., & Sung, L. K. (2017). Fair pay allocation decisions: From a regulatory focus theory view. Organizational Behavior and Human Decision Processes (SSCI), 142, 1-11 Carter, R., BaDham, R., Parker, S., Nesbit, P., & Sung, L. K. (2016). The effects of emPloyee engagement and self-efficacy on job performance: a longituDinal field stuDy. International Journal of Human Resource Management (SSCI), 1-20. Friedman, R., Liu, W., Chi, S. C, Hong, Y. Y. & Sung, L. K. (2012). Cross-cultural management and bicultural identity integration: When does experience abroad lead to appropriate cultural switching? International Journal of Intercultural Relations (SSCI), 36, 130-139 Chen, C. C., Tsai, W. C., Chen, H. Y., & Sung, L. K. (2009). APPlicant imPression management and interviewer decision: the moderating roles of note-taking anD warning of verification, Journal of Management (TSSCI, Journal in Chinese), 26, 577-897 Li-Kuo Sung – P.1 July 2020 Published Proceeding Kim, Eunhee, Sung, L. -
Conference Guide 会议手册
经济学院 School of Economics Fudan University 220 Handan Road, Shanghai 200433, China Tel: +86-21-65643821 Fax: +86-21-65112913 The Seventh International Conference on Futures and Other Derivatives 第七届期货与其他衍生品国际会议 Conference Guide 会议手册 Fudan-Stanford Institute for China Financial Technology and Risk Analytics Institute for Financial Studies Fudan University School of Data Science Fudan University 复旦-斯坦福中国金融科技与安全研究院 复旦大学金融研究院 复旦大学大数据学院 19th-20th October, 2018 2018 年 10 月 19-20 日 经济学院 School of Economics Fudan University 220 Handan Road, Shanghai 200433, China Tel: +86-21-65643821 Fax: +86-21-65112913 PROGRAM AT A GLANCE The Seventh International Conference on Futures and Other Derivatives Organized by Fudan University Conference Venue: School of Economics, Fudan University. No.600 Guoquan Road, Shanghai, China Friday 19: Dajin Report Hall (大金报告厅), School of Economics, Fudan University 12:30 pm – 1:20 pm Registration 1:20 pm -- 1:40 pm Chair Qingfu Liu, Executive Dean of Fudan-Stanford Institute for China Financial Technology Risk Analytics Opening Speech Jun Zhang, Dean of School of Economics, Fudan Univeristy 1:40 pm – 3:40 pm Chair Ke Tang, Tsinghua University Keynote Speaker Michael A.H.Dempster, University of Cambridge Chair Liyan Han, Beihang University Keynote Speaker Robert Webb, University of Virginia Chair Yunbi An, Windsor University Keynote Speaker Jianqing Fan, Fudan University and Princeton University 3:40 pm –4:00 pm Group Shot and Coffee Break 4:00 pm – 6:00 pm Chair Luyang Zhang, Fudan University Keynote Speaker Chongfeng Wu, -
Reply to Kesici Et Al. and Zeng Et Al.: Blocking the Virus and Reducing The
LETTER REPLY TO KESICI ET AL. AND ZENG ET AL.: Blocking the virus and reducing the inflammatory LETTER damage in COVID-19 Kai Duana,b,1, Bende Liuc,1, Cesheng Lid,1, Huajun Zhange,1, Ting Yuf,1, Jieming Qug,h,i,1, Min Zhoug,h,i,1, Li Chenj,1, Zhu Chenk,2, Xinxin Zhangl,2, and Xiaoming Yanga,b,2 We appreciate the constructive comments from Kesici macrophage infiltration and a further worsening of et al. (1) and Zeng et al. (2), which mainly focus on the lung injury. Therefore, the key point of CP therapy is key points about the optimal procedure of convales- to neutralize the virus and to interrupt the vicious cycle cent plasma (CP) transfusion in severe coronavirus dis- of excessive activation of the immune response in se- ease 2019 (COVID-19) therapy and about how to vere patients. In our study, 200 mL CP containing neu- improve the effectiveness. tralized antibody above 1:640 rapidly cleared the First of all, this study was a pilot trial and the aim viremia and achieved clinical improvement. Consider- was to investigate the safety of CP transfusion, which ing the accessibility of plasma donors, using CP as was defined as the primary endpoint (3). We neverthe- replacement fluid for the therapeutic plasma ex- less also explored the possible therapeutic benefits of change may be not feasible. CP by examining its effectiveness in neutralizing the Third, the optimal treatment time and dose of CP severe acute respiratory syndrome coronavirus 2 need to be determined by the knowledge on viral (SARS-CoV-2) and in ameliorating clinical symptoms proliferative kinetics.